Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Accumulated Expenses: 2009-2016

Historic Accumulated Expenses for Fresenius Medical Care AG (FMS) over the last 8 years, with Q4 2016 value amounting to $2.7 billion.

  • Fresenius Medical Care AG's Accumulated Expenses rose 599.44% to $2.7 billion in Q4 2016 from the same period last year, while for Dec 2016 it was $2.7 billion, marking a year-over-year increase of 599.44%. This contributed to the annual value of $2.7 billion for FY2016, which is 599.44% up from last year.
  • According to the latest figures from Q4 2016, Fresenius Medical Care AG's Accumulated Expenses is $2.7 billion, which was up 599.44% from $2.5 billion recorded in Q4 2015.
  • Over the past 5 years, Fresenius Medical Care AG's Accumulated Expenses peaked at $2.7 billion during Q4 2016, and registered a low of $1.7 billion during Q1 2012.
  • Over the past 5 years, Fresenius Medical Care AG's median Accumulated Expenses value was $2.0 billion (recorded in 2013), while the average stood at $2.1 billion.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 162.63% in 2013, then soared by 1911.88% in 2015.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Accumulated Expenses stood at $1.8 billion in 2012, then rose by 12.59% to $2.0 billion in 2013, then rose by 9.18% to $2.2 billion in 2014, then increased by 13.92% to $2.5 billion in 2015, then rose by 5.99% to $2.7 billion in 2016.
  • Its Accumulated Expenses was $2.7 billion in Q4 2016, compared to $2.5 billion in Q4 2015 and $2.3 billion in Q3 2015.